Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Mandell

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 15, 2000
Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of AmericaJ G Bartlett, S F Dowell, L A Mandell, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1983
A multicentre prospective randomized trial comparing ceftazidime with cefazolin/tobramycin in the treatment of hospitalized patients with non-pneumococcal pneumoniaL A Mandell, L E Nicolle, A R Ronald, et al.
The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses|May 3, 2012
Sequential antibiotic therapy: Effective cost management and patient careL A Mandell, M G Bergeron, M J Gribble, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistanceD J Bast, D E Low, C L Duncan, et al.
Journal of Chemotherapy (Florence, Italy)|February 3, 2007
Short-course therapy of gemifloxacin effective against pneumococcal pneumonia in miceD J Bast, L Dresser, C L Duncan, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2001
Interspecies recombination contributes minimally to fluoroquinolone resistance in Streptococcus pneumoniaeD J Bast, J C de Azavedo, T Y Tam, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2004
Novel murine model of pneumococcal pneumonia: use of temperature as a measure of disease severity to compare the efficacies of moxifloxacin and levofloxacinDarrin J Bast, M Yue, X Chen, et al.
The Journal of Infectious Diseases|September 1, 1989
Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind studyL A Mandell, M G Bergeron, A R Ronald, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1987
A prospective randomized trial of ceftazidime versus cefazolin/tobramycin in the treatment of hospitalized patients with pneumoniaL A Mandell, L E Nicolle, A R Ronald, et al.
The American Review of Respiratory Disease|November 1, 1993
Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung AssociationM S Niederman, J B Bass, G D Campbell, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 15, 2000
Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of AmericaJ G Bartlett, S F Dowell, L A Mandell, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1983
A multicentre prospective randomized trial comparing ceftazidime with cefazolin/tobramycin in the treatment of hospitalized patients with non-pneumococcal pneumoniaL A Mandell, L E Nicolle, A R Ronald, et al.
The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses|May 3, 2012
Sequential antibiotic therapy: Effective cost management and patient careL A Mandell, M G Bergeron, M J Gribble, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistanceD J Bast, D E Low, C L Duncan, et al.
Journal of Chemotherapy (Florence, Italy)|February 3, 2007
Short-course therapy of gemifloxacin effective against pneumococcal pneumonia in miceD J Bast, L Dresser, C L Duncan, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2001
Interspecies recombination contributes minimally to fluoroquinolone resistance in Streptococcus pneumoniaeD J Bast, J C de Azavedo, T Y Tam, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2004
Novel murine model of pneumococcal pneumonia: use of temperature as a measure of disease severity to compare the efficacies of moxifloxacin and levofloxacinDarrin J Bast, M Yue, X Chen, et al.
The Journal of Infectious Diseases|September 1, 1989
Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind studyL A Mandell, M G Bergeron, A R Ronald, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1987
A prospective randomized trial of ceftazidime versus cefazolin/tobramycin in the treatment of hospitalized patients with pneumoniaL A Mandell, L E Nicolle, A R Ronald, et al.
The American Review of Respiratory Disease|November 1, 1993
Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung AssociationM S Niederman, J B Bass, G D Campbell, et al.
Pageof 6